Elevated cytokines and chemokines in peripheral blood of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma.
The global SARS-CoV-2 coronavirus pandemic continues to be devastating in many areas. Treatment options have been limited and convalescent donor plasma has been used by many centers to transfer passive neutralizing antibodies to patients with respiratory involvement. The results often vary by instit...
Guardado en:
Autores principales: | Stacey L Fanning, Robert Korngold, Zheng Yang, Kira Goldgirsh, Steven Park, Joshua Zenreich, Melissa Baker, Phyllis McKiernan, Ming Tan, Bingsong Zhang, Michele L Donato, David S Perlin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6fcd1544d54d45469990610c74eb95e3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Elevated cytokines and chemokines in peripheral blood of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma
por: Stacey L. Fanning, et al.
Publicado: (2021) -
Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy
por: Abhinay Gontu, et al.
Publicado: (2021) -
Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response
por: Jonathan D. Herman, et al.
Publicado: (2021) -
Cytokines and Chemokines in HBV Infection
por: Shihong Zhong, et al.
Publicado: (2021) -
Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes
por: Takuya Tada, et al.
Publicado: (2021)